Pharmathene Q2 2008 Earnings Conference Call Transcript - Thomson StreetEvents

Pharmathene Q2 2008 Earnings Conference Call Transcript

Pharmathene Q2 2008 Earnings Conference Call Transcript - Thomson StreetEvents
Pharmathene Q2 2008 Earnings Conference Call Transcript
Published Aug 12, 2008
9 pages (4325 words) — Published Aug 12, 2008
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ALT.OQ earnings conference call or presentation 12-Aug-08 8:30pm GMT

  
Brief Excerpt:

...Operator Good day, ladies and gentlemen, and welcome to the Second Quarter 2008 PharmAthene Earnings Conference Call. My name is Ahmed and I will be your coordinator for today. At this time all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's conference. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today's conference, Stacey, Director of Corporate Communications. Stacey Jurchison ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Altimmune Inc
Ticker
ALT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : hi, good afternoon. Thank you for taking my call. I apologize, I'm rather new to the Company, so I'd like to start with a couple of background questions. First of all, how does your strategy for an rPA vaccine differ from those of your competitors? For example, the Walter Reed and IMA studies in development? Hello?

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Well, Walter Reed and IMA are doing some studies for an rPA vaccine and there is also some studies in development for one that comes through the skin.

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Okay, so you're saying - I'm sorry, you said that IMA uses the same rPA that you do? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Okay, you do. And also, does your vaccine contain any agivents, and if so, which ones?

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Almun?

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Alumin, okay. And in any of your animal or human studies have you done any studies as to the antibody response in different animals or different humans and how they differ, what the variability is?

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : In either your animal studies or your clinical trials, have you ever studied antibody titers in response to the vaccine and just wondering what the -

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : No, no. what I'm trying to ask is, is there a difference in terms of the number of - or the concentration of antibodies that different individuals produce in response to your vaccine? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.

Question: Natalie Rapute - Rodman & Renshaw Capital Group, Inc. - Analyst : Okay, okay thank you very much.

Table Of Contents

Pharmathene Q1 2009 Earnings Conference Call Transcript – 2009-05-15 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 15-May-09 2:00pm GMT

SparVax rPA Anthrax Vaccine Update Transcript – 2009-04-29 – US$ 54.00 – Edited Transcript of ALT.OQ conference call or presentation 29-Apr-09 8:30pm GMT

Pharmathene Q4 2008 Earnings Conference Call Transcript – 2009-03-30 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 30-Mar-09 8:30pm GMT

Pharmathene Q3 2008 Earnings Conference Call Transcript – 2008-11-13 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 13-Nov-08 9:30pm GMT

Pharmathene at UBS Global Life Sciences Conference Transcript – 2008-09-25 – US$ 54.00 – Edited Transcript of ALT.OQ presentation 25-Sep-08 5:30pm GMT

Pharmathene Q1 2008 Earnings Conference Call Transcript – 2008-05-13 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 13-May-08 8:30pm GMT

Pharmathene Q4 2007 Earnings Conference Call Transcript – 2008-03-31 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 31-Mar-08 8:30pm GMT

Pharmathene Discussion of Avecia Acquisition Conference Call Transcript – 2008-03-20 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 20-Mar-08 8:30pm GMT

PharmAthene, Inc at BIO CEO & Investor Conference Transcript – 2008-02-13 – US$ 54.00 – Edited Transcript of ALT.OQ presentation 13-Feb-08 5:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Pharmathene Q2 2008 Earnings Conference Call Transcript" Aug 12, 2008. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2008-Pharmathene-Earnings-Conference-Call-T1893866>
  
APA:
Thomson StreetEvents. (2008). Pharmathene Q2 2008 Earnings Conference Call Transcript Aug 12, 2008. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2008-Pharmathene-Earnings-Conference-Call-T1893866>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.